Abstract
Technological advances in the form of next-generation sequencing allow sequencing of large numbers of different DNA sequences in a single/parallel reaction compared to conventional sequencing. It is a powerful tool which has enabled comprehensive characterization of esophageal squamous cell carcinoma. Whole-genome sequencing is the most comprehensive but expensive, whereas whole-exome sequencing is cost-effective, but it only works for the known genes. Thus, second-generation sequencing methods can provide a complete picture of the esophageal squamous cell carcinoma genome by detecting and discovering different type of alterations in the cancer which may lead to the development of effective diagnostic and therapeutic approaches for esophageal squamous cell carcinoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74:5463–5467
Rizzo JM, Buck MJ (2012) Key principles and clinical applications of "next-generation" DNA sequencing. Cancer Prev Res 5:887–900
Pillai S, Gopalan V, Lam AK (2017) Review of sequencing platforms and their applications in phaeochromocytoma and paragangliomas. Crit Rev Oncol Hematol 116:58–67
Mardis ER (2013) Next-generation sequencing platforms. Annu Rev Anal Chem 6:287–303
Sasaki Y, Tamura M, Koyama R et al (2016) Genomic characterization of esophageal squamous cell carcinoma: insights from next-generation sequencing. World J Gastroenterol 22:2284–2293
Lohmann K, Klein C (2014) Next generation sequencing and the future of genetic diagnosis. Neurotherapeutics 11:699–707
Golyan FF, Moghaddassian M, Forghanifard MM et al (2019) Whole exome sequencing reveals a novel damaging mutation in human fibroblast activation protein in a family with esophageal squamous cell carcinoma. J Gastrointest Cancer. (In press) https://doi.org/10.1007/s12029-019-00224-x
Lin DC, Dinh HQ, Xie JJ et al (2018) Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas. Gut 67:1769–1779
Xing S, Zheng X, Wei LQ et al (2017) Development and validation of a serum biomarker panel for the detection of esophageal squamous cell carcinoma through RNA transcriptome sequencing. J Cancer 8:2346–2355
Song Y, Li L, Ou Y et al (2014) Identification of genomic alterations in oesophageal squamous cell cancer. Nature 509:91–95
Agrawal N, Jiao Y, Bettegowda C et al (2012) Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov 2:899–905
Forouzanfar N, Baranova A, Milanizadeh S et al (2017) Novel candidate genes may be possible predisposing factors revealed by whole exome sequencing in familial esophageal squamous cell carcinoma. Tumour Biol 39:1010428317699115
Gao YB, Chen ZL, Li JG et al (2014) Genetic landscape of esophageal squamous cell carcinoma. Nat Genet 46:1097–1020
Ma S, Bao JYJ, Kwan PS et al (2012) Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma. Gastroenterology 143:675–686
Lin DC, Hao JJ, Nagata Y et al (2014) Genomic and molecular characterization of esophageal squamous cell carcinoma. Nat Genet 46:467–473
Bainbridge MN, Wang M, Burgess DL et al (2010) Whole exome capture in solution with 3 Gbp of data. Genome Biol 11:R62
Sun M, Ju H, Zhou Z (2014) Pilot genome-wide study of tandem 3’ UTRs in esophageal cancer using high-throughput sequencing. Mol Med Rep 9:1597–1605
Zhang J, Chen Z, Tang Z et al (2017) RNA editing is induced by type I interferon in esophageal squamous cell carcinoma. Tumour Biol 39:1010428317708546
Wang K, Johnson A, Ali SM et al (2015) Comprehensive genomic profiling of advanced esophageal squamous cell carcinomas and esophageal adenocarcinomas reveals similarities and differences. Oncologist 20:1132–1139
Cheng C, Cui H, Zhang L et al (2016) Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma. Gigascience 5:1
Kishino T, Niwa T, Yamashita S et al (2016) Integrated analysis of DNA methylation and mutations in esophageal squamous cell carcinoma. Mol Carcinog 55:2077–2088
Nakazato H, Takeshima H, Kishino T et al (2016) Early-stage induction of SWI/SNF mutations during esophageal squamous cell carcinogenesis. PLoS One 11:e0147372
Luo H, Li H, Hu Z et al (2016) Noninvasive diagnosis and monitoring of mutations by deep sequencing of circulating tumor DNA in esophageal squamous cell carcinoma. Biochem Biophys Res Commun 471:596–602
Welander J, Andreasson A, Juhlin CC et al (2014) Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 99:1352–1360
Pan Z, Mao W, Bao Y et al (2016) The long noncoding RNA CASC9 regulates migration and invasion in esophageal cancer. Cancer Med 5:2442–2447
Ueda M, Iguchi T, Masuda T et al (2016) Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence. Oncotarget 7:62280–62291
Hao JJ, Lin DC, Dinh HQ et al (2016) Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma. Nat Genet 48:1500–1507
Zheng H, Wang Y, Tang C et al (2016) TP53, PIK3CA, FBXW7 and KRAS mutations in esophageal cancer identified by targeted sequencing. Cancer Genomics Proteomics 13:231–238
Quail MA, Smith M, Coupland P et al (2012) A tale of three next generation sequencing platforms: comparison of ion torrent, Pacific biosciences, and Illumina MiSeq sequencers. BMC Genomics 13:341
Liu X, Zhang M, Ying S et al (2017) Genetic alterations in esophageal tissues from squamous dysplasia to carcinoma. Gastroenterology 153:166–177
Yang JW, Choi YL (2017) Genomic profiling of esophageal squamous cell carcinoma (ESCC)-basis for precision medicine. Pathol Res Pract 213:836–841
Kobayashi S, Yamaguchi T, Maekawa S et al (2018) Target sequencing of cancer-related genes in early esophageal squamous neoplasia resected by endoscopic resection in Japanese patients. Oncotarget 9:36793–36803
Lin ZW, Gu J, Liu RH et al (2014) Genome-wide screening and co-expression network analysis identify recurrence-specific biomarkers of esophageal squamous cell carcinoma. Tumour Biol 35:10959–10968
Yokota T, Serizawa M, Hosokawa A et al (2018) PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue. BMC Cancer 18:826
van El CG, Cornel MC, Borry P et al (2013) Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics. Eur J Hum Genet 21:1–5
Meyerson M, Gabriel S, Getz G (2010) Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 11:685–696
Sims D, Sudbery I, Ilott NE et al (2014) Sequencing depth and coverage: key considerations in genomic analyses. Nat Rev Genet 15:121–132
Zhang L, Zhou Y, Cheng C et al (2015) Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet 96:597–611
Chang J, Tan W, Ling Z et al (2017) Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations. Nat Commun 8:15290
Chen Z, Zhang C, Pan Y et al (2016) T cell receptorβ-chain repertoire analysis reveals intratumour heterogeneity of tumour-infiltrating lymphocytes in oesophageal squamous cell carcinoma. J Pathol 239:450–458
Rabbani B, Tekin M, Mahdieh N (2014) The promise of whole-exome sequencing in medical genetics. J Hum Genet 59:5–15
Parla JS, Iossifov I, Grabill I et al (2011) A comparative analysis of exome capture. Genome Biol 12:97
Zhu Q, Hu Q, Shepherd L et al (2015) The impact of DNA input amount and DNA source on the performance of whole-exome sequencing in cancer epidemiology. Cancer Epidemiol Biomark Prev 24:1207–1213
Wang Z, Gerstein M, Snyder M (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10:57–63
Peng X, Xue H, Lü L et al (2017) Accumulated promoter methylation as a potential biomarker for esophageal cancer. Oncotarget 8:679–691
Margulies M, Egholm M, Altman WE et al (2005) Genome sequencing in microfabricated high-density picolitre reactors. Nature 43:376–380
Pareek CS, Smoczynski R, Tretyn A (2011) Sequencing technologies and genome sequencing. J Appl Genet 52:413–435
Li X, Buckton AJ, Wilkinson SL et al (2013) Towards clinical molecular diagnosis of inherited cardiac conditions: a comparison of bench-top genome DNA sequencers. PLoS One 8:e67744
Ballester LY, Luthra R, Kanagal-Shamanna R et al (2016) Advances in clinical next-generation sequencing: target enrichment and sequencing technologies. Expert Rev Mol Diagn 16:357–372
Wang W, Wei C, Li P et al (2018) Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma. Gene 661:169–175
Moorthie S, Mattocks CJ, Wright CF (2011) Review of massively parallel DNA sequencing technologies. HUGO J 5:1–12
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Pillai, S., Maksemous, N., Lam, A.K. (2020). Genome Sequencing in Esophageal Squamous Cell Carcinoma. In: Lam, A. (eds) Esophageal Squamous Cell Carcinoma. Methods in Molecular Biology, vol 2129. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0377-2_17
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0377-2_17
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0376-5
Online ISBN: 978-1-0716-0377-2
eBook Packages: Springer Protocols